Theravance Biopharma (NASDAQ:TBPH) Receives Buy Rating from HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) in a research report report published on Tuesday,Benzinga reports. They currently have a $15.00 price objective on the biopharmaceutical company’s stock. Theravance Biopharma Trading Up 1.2 % TBPH opened at $8.97 on Tuesday. Theravance Biopharma has a 12-month low of […]
HC Wainwright reaffirmed their buy rating on shares of Theravance Biopharma (NASDAQ:TBPH – Free Report) in a research report report published on Tuesday,Benzinga reports. They currently have a $15.00 price objective on the biopharmaceutical company’s stock. Theravance Biopharma Trading Up 1.2 % TBPH opened at $8.97 on Tuesday. Theravance Biopharma has a 12-month low of […]
